These job announcements are intended to highlight some of the hiring news from the past month and are not comprehensive.If you would like to share job listings or announcements on our website, please contact Liu Weini In this email: winnie@breakmedia.com.
This Biden administration appointment PhD.Ash JaaDean of Brown University’s School of Public Health as the next White House Covid-19 response coordinator. He succeeds Jeffrey Zients, who has held the role since Joe Biden’s presidency.This convention Starting April 5th. For more information, Click here.
Norman “Ned” Sharpless, MD is resigning from his directorship National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017. Sharpless will continue to serve as NCI Director until April 29, 2022, to ease the transition. Principal Deputy Director of NCI Douglas Lowy MD Will be acting director of NCI from April 30, 2022. For more information, Click here.
Novartis Made some changes to its executive board:
- Marie-France Chudin already appointment President and Chief Commercial Officer of International Innovative Medicines
- Victor Trump already appointment President of American Innovative Medicines
- Dr. Stephen Longalready appointment President, Operations
- Shreeram Aradhye MD already appointment President, Global Drug Development and Chief Medical Officer
- Novartis’ departures include:
- Dr. Susan Shaffert President of Novartis Oncology
- Robert WeltfriedenPresident of Customer and Technology Solutions
- John Tsai, MD President, Global Drug Development and Chief Medical Officer
To read more information, Click here.
MerckHead of Global Clinical Development and Chief Medical Officer of Merck Research Laboratories, Dr. Roy Baines, will retire from Merck in July.he has been succeeded Dr. Eliav Barreffective April 1.
Baynes will continue to report to Dr. Dean Y. Li, President of Merck Research Laboratories until his retirement.
During more than two decades at Merck, Barr has held roles of increasing importance, including leadership roles in oncology and infectious disease clinical development. He oversaw the company’s vaccine/infectious disease area during the development of new treatments for chronic hepatitis C and HIV-1 infection. Most recently, he led MRL’s global medical affairs organization from 2018 to January 2022, significantly expanding Merck’s scientific engagement and implementation efforts in oncology, vaccines, and more. to know more information, Click here.
Reaction Biologyan industry-leading provider of drug discovery services, has appointed Richard Colender The positions of CFO, CBO and Executive Committee members, effective immediately, will further strengthen the leadership team and support the company’s next phase of growth. to know more information, Click here.
etc appointed Dr. Scott Cahill as Chief Commercial Officer. The Oxford-based company is harnessing the power of the adaptive immune system to transform the precision, scale and speed of TCR immunotherapy development.
Cuthill previously held senior business development roles at Valo Therapeutics in Finland. Before that, he worked at Chroma Therapeutics and Ipsen Biopharma. to know more information, Click here.
immune mediated appointed Jeff Bocherdin As CEO of its US subsidiary Immunovia, Inc. He joins Myriad Genetics, one of America’s leading diagnostic companies, as Chief Marketing Officer. Borcherding will be part of the Immunovia Group’s management team from 11 April. For more information, Click here.
Oratek Therapyleader in developing class-selective NLRP3 inhibitors, has named pharma industry veteran Mustafa Noor, MD As Chief Medical Officer, following the decision of current Chief Marketing Officer Dr. Curt Scribner to retire. to know more information, Click here.
mesoderma company developing allogeneic cellular medicines for inflammatory diseases announced, Philip Krause, MD has joined its board of directors.
For the past decade, Krause has served as Deputy Director of the Office of Vaccine Research and Review in the FDA’s Center for Biologics Evaluation and Research. He is currently Chair of the World Health Organization’s Expert Group on Covid Vaccine Research and most recently co-responsible for the regulatory authorization of a Covid-19 vaccine in the United States. Click here.
CareFirst BlueCross Blue Shield Board Certified Family Physician Appointed Djinge Lindsay, MD as its new Director of Public Health.
In this new role, Lindsay will lead a new public health infrastructure team focused on improving health outcomes and health equity in all aspects of the healthcare experience. By leveraging its data to understand where health disparities exist and what factors, such as social determinants of health, are driving those differences, companies can implement actionable and tailored responses for our members and communities. CareFirst will serve as an active partner to local health organizations, health ministries, academic institutions and employers to develop strategies across all industries to better serve people across the region, with a focus on accessibility, affordability and meaningful impact on quality of care. to know more information, Click here.
Synchronized thinkinga next-generation neurotechnology company and developer of the award-winning EYE-SYNC technology, today announced the expansion of its clinical advisory board and the creation of a select advisory group of physical therapy providers to assist the company with its growing offering demand and market opportunities.
They include:
- Erin Ethanhart
- Thomas Factory
- Bobby Jane Lee
- Chelsea Ortega
They will work closely with the company to raise the profile of the physical therapy industry, support new product development efforts, and serve as ambassadors for other healthcare and sports providers. These new physical therapy consultants will join current Massachusetts General Hospital consultant and physical therapist Lenore Herget and Marie Boo of the U.S. Women’s National Soccer Team.
to know more information, Click here.
Binks Health, A health technology and diagnostics company that makes routine testing convenient by enabling people to access care where they live, work, study and shop appointment Todd Bennett as Chief Commercial Officer. Bennett has held various executive leadership positions at high growth companies including Luminex, Immucor, Roche and Abbott. to know more information, Click here.
eHealth Technology Hired two executives:
- Dan Torrance Has been named CEO and succeeds Jeff Markin, who will continue in an advisory role. Torrens most recently served as Chief Operating Officer of ConnectiveRx.
- Sean WeissFormerly with the CMMI Institute, has been named Vice President of Engineering.
- Jeff Friar Promoted to Vice President of Operations.
Photo: Marchmeena29, Getty Images
